Anja Karlstaedt
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Cardiovascular Function and Risk Factors 4
- Cardiomyopathy and Myosin Studies 3
-
- Cancer, Hypoxia, and Metabolism 10
-
- Mitochondrial Function and Pathology 11
- Metabolism, Diabetes, and Cancer 5
- Metabolomics and Mass Spectrometry Studies 2
-
- Advanced MRI Techniques and Applications 3
Anja Karlstaedt
27 papers receiving 704 citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Cardiology and Cardiovascular Medicine 204
- Cancer Research 89
- Molecular Biology 390
- Molecular Medicine 23
- Endocrinology 20
Countries citing papers authored by Anja Karlstaedt
This map shows the geographic impact of Anja Karlstaedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Karlstaedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Karlstaedt more than expected).
Fields of papers citing papers by Anja Karlstaedt
This network shows the impact of papers produced by Anja Karlstaedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Karlstaedt. The network helps show where Anja Karlstaedt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anja Karlstaedt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 6 | |
| 5 | Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomasbreakdown → | 2024 | 52 |
| 6 | 2024 | 6 | |
| 7 | 2024 | 1 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 59 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 26 | |
| 13 | 2021 | 30 | |
| 14 | 2020 | 63 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 42 | |
| 17 | 2018 | 18 | |
| 18 | 2017 | 23 | |
| 19 | 2017 | 197 | |
| 20 | 2017 | 16 |
About Anja Karlstaedt
Anja Karlstaedt is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Clinical Biochemistry, having authored 27 papers that have together received 713 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Cardiovascular Function and Risk Factors (4 papers), Advanced MRI Techniques and Applications (3 papers), Cardiomyopathy and Myosin Studies (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (204 citations), Cancer Research (89 citations) and Molecular Biology (390 citations). Anja Karlstaedt has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Heinrich Taegtmeyer, Heidi Vitrac, William Dowhan, Venkata Mallampalli, William Margolin, Veronica W. Rowlett, Rudolf A. de Boer, Javid J. Moslehi, Margaret A. Goodell and Hernán Vásquez.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.